PPA
CTSO icon

Parametric Portfolio Associates’s Cytosorbents Corp CTSO Stock Holding History

Parametric Portfolio Associates’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$246K Buy
76,978
+58,491
+316% +$209K ﹤0.01% 3363
2021
Q4 		$77K Sell
18,487
-3,313
-15% -$18.6K ﹤0.01% 3575
2021
Q3 		$177K Buy
21,800
+7,279
+50% +$59.1K ﹤0.01% 3459
2021
Q2 		$110K Sell
14,521
-1,295
-8% -$10.9K ﹤0.01% 3473
2021
Q1 		$137K Buy
15,816
+100
+0.6% +$953 ﹤0.01% 3938
2020
Q4 		$125K Buy
15,716
+459
+3% +$3.84K ﹤0.01% 3860
2020
Q3 		$122K Sell
15,257
-153
-1% -$1.38K ﹤0.01% 3760
2020
Q2 		$153K Buy
15,410
+219
+1% +$2.01K ﹤0.01% 3699
2020
Q1 		$117K Buy
15,191
+4,936
+48% +$24.9K ﹤0.01% 3687
2019
Q4 		$39K Buy
+10,255
New +$44.7K ﹤0.01% 3932

Other funds holding CTSO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Parametric Portfolio Associates's CTSO Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Cytosorbents Corp (CTSO) stake by 316% in Q1 2022, buying an estimated $209K and bringing the position to 76,978 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #3363.

Parametric Portfolio Associates first reported a position in CTSO in Q4 2019 and has held it in 10 quarters since. 88 funds tracked by Wall St. Rank hold CTSO as of Q1 2022.

  • Parametric Portfolio Associates held 76,978 shares of Cytosorbents Corp worth $246K as of Q1 2022.
  • Parametric Portfolio Associates bought 58,491 Cytosorbents Corp shares in Q1 2022, an estimated $209K.
  • Cytosorbents Corp made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3363 holding.
  • Parametric Portfolio Associates first reported a position in Cytosorbents Corp in Q4 2019 and has held it in 10 quarters since.
  • 88 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.